Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Centogene N.V.
  6. News
  7. Summary
    CNTG   NL0014040206

CENTOGENE N.V.

(CNTG)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Centogene N : Credit Suisse Lowers Centogene's PT to $14 from $15 After Weaker-than-Expected Q1 Profitability, Keeps Outperform Rating

06/17/2021 | 09:47am EDT


© MT Newswires 2021
All news about CENTOGENE N.V.
06/25AIR CANADA : Introduces Digital Solution to Simplify COVID-19 Related Travel Req..
MT
06/25Centogene N.V. Appoints Rene Just as Managing Director
CI
06/25CENTOGENE Announces Shareholders Approve All Resolutions at Annual General Me..
GL
06/22CENTOGENE N : Focuses on leveraging its unique rare disease-centric Bio/Databank..
PU
06/22PRESS RELEASE : CENTOGENE Sets Mission to Enable -2-
DJ
06/22PRESS RELEASE : CENTOGENE Sets Mission to Enable the Cure of 100 Rare Diseases W..
DJ
06/22CENTOGENE Sets Mission to Enable the Cure of 100 Rare Diseases Within the Nex..
GL
06/17CENTOGENE N : Credit Suisse Lowers Centogene's PT to $14 from $15 After Weaker-t..
MT
06/16CENTOGENE N : Announced key additions to the management team, including Rene Jus..
PU
06/16Centogene N.V. Announces Unaudited Consolidated Impairment Charges for the Fi..
CI
More news
Financials
Sales 2021 144 M 169 M 169 M
Net income 2021 -28,3 M -33,3 M -33,3 M
Net cash 2021 13,7 M 16,2 M 16,2 M
P/E ratio 2021 -7,54x
Yield 2021 -
Capitalization 216 M 254 M 254 M
EV / Sales 2021 1,40x
EV / Sales 2022 3,11x
Nbr of Employees 660
Free-Float 40,0%
Chart CENTOGENE N.V.
Duration : Period :
Centogene N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CENTOGENE N.V.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 9,62 €
Average target price 16,30 €
Spread / Average Target 69,5%
EPS Revisions
Managers and Directors
Andrin Oswald Chief Executive Officer
Richard Stoffelen Chief Financial & Accounting Officer
Peer Michael Schatz Chairman-Supervisory Board
Volkmar Weckesser Chief Information Officer
Philip Lambert Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
CENTOGENE N.V.5.01%241
MODERNA, INC.233.90%88 312
LONZA GROUP AG24.05%53 538
IQVIA HOLDINGS INC.39.02%47 022
CELLTRION, INC.-25.21%32 170
SEAGEN INC.-16.87%28 525